Can a new HER2-targeted therapy improve outcomes for patients with gastroesophageal cancer? Professor Shen Lin from Peking University Cancer Hospital led the global Phase III HERIZON-GEA-01 study evaluating zanidatamab-based treatments for HER2-positive gastroesophageal

Peking University @PKU1898 · 2026-07-03

Can a new HER2-targeted therapy improve outcomes for patients with gastroesophageal cancer? Profess…

更多来自 @PKU1898

#1
Upcoming lecture in the PKU Global Fellowship Series: Prof. Frank Neese, Director & Managing Director of the Max Planck Institute for Coal Research, will present New Developme…
Peking University @PKU1898 · 2026-07-27
#2
Prof. Garnet Chan, Bren Professor of Chemistry at Caltech, Member of the US National Academy of Sciences, Fellow of the Royal Society (FRS), and Member of the International Academ…
Peking University @PKU1898 · 2026-07-27
#3
Passion, patience, and persistence. The "Best Students" in Nobel Laureate Prof. Schekman's lab know what to do next without being told. If you love the challenges and can keep goi…
Peking University @PKU1898 · 2026-07-27
#4
"Most people are too conservative when it comes to taking risks." From DNA replication in graduate school to pioneering vesicle traffic research, Nobel Laureate Prof. Randy Schekm…
Peking University @PKU1898 · 2026-07-26
#5
A new approach to acoustic simulation from PKU could support future work in embodied intelligence! The research team led by Li Sheng and Wang Guoping from the School of Computer S…
Peking University @PKU1898 · 2026-07-26
#6
Loss changed his life, and science became his way to give back. During his visit to PKU, Nobel Laureate Prof. Randy Schekman told us why he donated his Nobel Prize money. From pub…
Peking University @PKU1898 · 2026-07-25

查看 @PKU1898 的全部帖子